The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $16.11

Today's change+0.50 +3.24%
Updated April 26 12:12 PM EDT. Delayed by at least 15 minutes.
 

Tenet Healthcare Corp

NYSE: THC
Last

(U.S.) $16.11

Today's change+0.50 +3.24%
Updated April 26 12:12 PM EDT. Delayed by at least 15 minutes.

Tenet Healthcare Corp up sharply

Tenet Healthcare Corp is up sharply today, rallying (U.S.)$0.50 or 3.24% to (U.S.)$16.11. Over the last five days, shares have gained 4.04% and 8.52% year to date. Shares have underperformed the S&P 500 by 65.04% during the last year.

Key company metrics

  • Open(U.S.) $15.76
  • Previous close(U.S.) $15.60
  • High(U.S.) $16.13
  • Low(U.S.) $15.73
  • Bid / Ask(U.S.) $16.10 / (U.S.) $16.11
  • YTD % change+8.52%
  • Volume1,361,334
  • Average volume (10-day)3,712,659
  • Average volume (1-month)3,603,865
  • Average volume (3-month)3,249,196
  • 52-week range(U.S.) $14.06 to (U.S.) $34.08
  • Beta1.37
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward13.48×
  • Forward PEG0.97×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.88
Updated April 26 12:12 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+0.92%

Based on its net profit margin of 0.92%, Tenet Healthcare Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.09%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue4,8604,8494,8685,044
Total other revenue--------
Total revenue4,8604,8494,8685,044
Gross profit4,0874,0824,0954,233
Total cost of revenue773767773811
Total operating expense4,5884,5164,6014,697
Selling / general / administrative2,3242,3142,3162,402
Research & development--------
Depreciation / amortization218205215212
Interest expense (income), net operating--------
Unusual expense (income)1233213554
Other operating expenses, total1,1961,2291,1921,242
Operating income272333267347
Interest income (expense), net non-operating-249-243-244-243
Gain (loss) on sale of assets--------
Other--------
Income before tax298925105
Income after tax23794138
Income tax, total610-1667
Net income-79-8-46-59
Total adjustments to net income--------
Net income before extra. items-79-9-44-55
Minority interest-102-88-85-93
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-79-9-44-55
Inc. avail. to common incl. extra. items-79-8-46-59
Diluted net income-79-8-46-59
Dilution adjustment--------
Diluted weighted average shares1001009999
Diluted EPS excluding extraordinary itemsvalue per share-0.79-0.09-0.44-0.56
Dividends per sharevalue per share--0.000.000.00
Diluted normalized EPSvalue per share0.190.190.44-0.20